Real-World Study Evaluates Semaglutide for Severe Obesity in Diverse Patient Groups

SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials. Authors: Bel Lassen P, Jacobi D, Brindisi MC, Bonnet JB, Subtil F, Bin S, Abad F, Poitou C, Segrestin B…